Search Results - "Datir RP"

Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.

Authors: Kemp SA Collier DA Datir RP et al.

Corporate Authors: Kemp SA Collier DA Datir RP et al.

Source: Nature [Nature] 2022 Aug; Vol. 608 (7922), pp. E23.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE

Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

Authors: Collier DA De Marco A Ferreira IATM et al.

Corporate Authors: Collier DA De Marco A Ferreira IATM et al.

Source: Nature [Nature] 2022 Aug; Vol. 608 (7922), pp. E24.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy.

Authors: Deo, Rinki Choudhary, Manish C Glover, Owen T et al.

Source: Open Forum Infectious Diseases. Sep2025, Vol. 12 Issue 9, p1-4. 4p.

Dynamics of lung-infiltrating virus-specific T cells associated with age-dependent SARS-CoV-2 pneumonia severity.

Authors: Kurokawa, Rise Mtali, Chatherine Silas Daniel, Innocent John et al.

Source: PLoS Pathogens. 1/14/2026, Vol. 22 Issue 1, p1-22. 22p.

Genomic and epidemiologic characteristics of SARS-CoV-2 persistent infections in California, January 2021 - July 2023.

Authors: Bell, John M. Elder, Jesse Ryder, Rahil et al.

Source: PLoS Pathogens. 11/10/2025, Vol. 21 Issue 11, p1-21. 21p.

Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data.

Authors: Deichmann, Julia Barda, Noam Canetti, Michal et al.

Source: PLoS Computational Biology. 6/18/2025, Vol. 21 Issue 6, p1-16. 16p.

Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy.

Authors: Jacobs, Jana L Haidar, Ghady Naqvi, Asma et al.

Source: Open Forum Infectious Diseases. May2023, Vol. 10 Issue 5, p1-5. 5p.

A Bibliometric Analysis on Multi-epitope Vaccine Development Against SARS-CoV-2: Current Status, Development, and Future Directions.

Authors: Khalid, Kanwal Ahmad, Fiaz Anwar, Ayaz et al.

Source: Molecular Biotechnology. Jan2026, Vol. 68 Issue 1, p1-22. 22p.

In depth sequencing of a serially sampled household cohort reveals the within-host dynamics of Omicron SARS-CoV-2 and rare selection of novel spike variants.

Authors: Bendall, Emily E. Dimcheff, Derek Papalambros, Leigh et al.

Source: PLoS Pathogens. 4/28/2025, Vol. 21 Issue 4, p1-17. 17p.

Variable rates of SARS-CoV-2 evolution in chronic infections.

Authors: Smith, Ewan W. Hamilton, William L. Warne, Ben et al.

Source: PLoS Pathogens. 4/28/2025, Vol. 21 Issue 4, p1-22. 22p.

Evolution of SARS-CoV-2 in white-tailed deer in Pennsylvania 2021–2024.

Authors: Marques, Andrew D. Hogenauer, Matthew Bauer, Natalie et al.

Source: PLoS Pathogens. 1/24/2025, Vol. 21 Issue 1, p1-28. 28p.

Examining the molecular clock hypothesis for the contemporary evolution of the rabies virus.

Authors: Durrant, Rowan Cobbold, Christina A. Brunker, Kirstyn et al.

Source: PLoS Pathogens. 11/25/2024, Vol. 20 Issue 11, p1-15. 15p.

Unravelling the link between SARS-CoV-2 mutation frequencies, patient comorbidities, and structural dynamics.

Authors: Azzeri, Amirah Mohamed, Nurul Azmawati Wan Rosli, Saarah Huurieyah et al.

Source: PLoS ONE. 3/14/2024, Vol. 19 Issue 3, p1-15. 15p.

Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.

Authors: Schoefbaenker, Michael Günther, Theresa Lorentzen, Eva Ulla et al.

Source: PLoS Pathogens. 10/15/2024, Vol. 20 Issue 10, p1-27. 27p.

SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy.

Authors: Bolis, Matteo Uceda Renteria, Sara Alagna, Laura et al.

Source: BMC Infectious Diseases. 3/14/2025, Vol. 25 Issue 1, p1-9. 9p.

Structural prediction of chimeric immunogen candidates to elicit targeted antibodies against betacoronaviruses.

Authors: Simpson, Jamel Kasson, Peter M.

Source: PLoS Computational Biology. 2/5/2025, Vol. 21 Issue 2, p1-20. 20p.

A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/Ritonavir.

Authors: Snell, Luke B McGreal-Bellone, Aimee Nye, Clemency et al.

Source: Open Forum Infectious Diseases. Jan2024, Vol. 11 Issue 1, p1-4. 4p.

Molecular characterization of a unique Recombinant form of HIV-1 subtype F2/CRF02_AG identified in Guangdong, China.

Authors: Ling, Xuemei Lin, Yaqing Li, Linghua et al.

Source: Virology Journal. 10/14/2025, Vol. 22 Issue 1, p1-10. 10p.

Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.

Authors: Guisado-Vasco, P. Carralón-González, M. M. Aguareles-Gorines, J. et al.

Source: Journal of Hematology & Oncology. 1/10/2022, Vol. 15 Issue 1, p1-4. 4p.

Genomic and epidemiological analysis of SARS-CoV-2 variants isolated in Guinea: a routine sequencing implementation.

Authors: Mbaye, Aminata Diallo, Haby Gnimadi, Thibaut Armel Cherif et al.

Source: BMC Infectious Diseases. 1/2/2025, Vol. 25 Issue 1, p1-13. 13p.